Abbott announced it has received European CE Mark approval for the Esprit below-the-knee (BTK) everolimus-eluting resorbable ...

A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, ...

A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) ...

Patient throughput and management of GI bleeds, from initial presentation through definitive management. Gastrointestinal (GI ...

A Q&A addressing common questions around coding, payment models, and value-based care alignment for percutaneous transmural ...

Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, ...

After the 2018 Journal of the American Heart Association (JAHA) meta-analysis suggesting an early mortality signal in ...

Michael Chen, MD Professor of Neurology, Neurosurgery & Radiology Rush University Medical Center Chicago, Illinois [email protected] ...

Reflections on what is lost and gained when a well-designed trial produces unexpected results.

The evolution of EVAR follow-up protocols reflects a broader trend toward precision, patient-centered care. By integrating patient-specific risk factors, procedural details, and advanced imaging ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...